"Bioresorbable vascular scaffold market to exhibit dynamic growth during the forecast period"

The global bioresorbable vascular scaffold market is growing proficiently, expected to grow at a CAGR of 10.3%. Worldwide, the increasing prevalence of coronary heart-related disorders and other cardiovascular disorders will drive the growth of the market. Increasing awareness about new bioabsorbable technology to overcome the limitations by permanent metallic endoprosthesis along with the launch of advanced cardiac stents with integrated solutions will boost the overall demand in the developed nations. Top-quality improved biomaterials (metal or polymer) are few of the major factors driving the demand of bioresorbable vascular scaffold market on a global scale.

"Polymer based stents segment expected to register higher growth by the end of 2027"

Advancement in polymer bioabsorbable scaffolds along with the development in the field of metal alloys will drive the market growth. These stents, without any external intervention prevent restenosis and thrombosis. For e.g. Magmaris, it is the first clinically proven coronary resorbable magnesium alloy scaffold, released by Biotronik. Advancement in polymer technology along with biological vascular scaffolds will enhance market growth. In July 2016, the U.S FDA approved Absorb GT1 bioresorbable vascular scaffold system (BVS) made from a polymer called poly (L-lactide). New product development, rising hospital admissions for ischemic heart disease along with by-pass cardiac surgical procedures will drive the market growth on a global scale.

"Coronary heart diseases to witness a significant CAGR"

Growing hospital admissions for coronary heart disease and its surgical treatment generated maximum market share in 2018. Moreover, huge patient pool with cardiovascular-related disorders on a global scale will drive the market growth globally. In 2017, according to statistics by WHO, cardiovascular disease accounted for more than 17.5 million deaths globally, majorly due to heart attack and stroke. Additionally, the increasing prevalence for ischemic heart disease, acute coronary syndrome, and peripheral artery related conditions will drive the overall demand for bioresorbable vascular scaffold market. Advancement in synthetic technology, FDA approval for advanced products, and increasing geriatric and obese population offers a huge advantage in the global stent industry.

"Increased research and development with strong product pipelines in the developed regions"

Major players in the bioresorbable vascular scaffold market are Cook Medical, Medtronic, plc., Abbott Laboratories, Stentys SA, C. R. Bard, Inc., MAQUET Holding B.V. & Co. KG, Boston Scientific Corporation, Terumo Corporation, W.L. Gore & Associates, Boston Scientific Corporation, AngioDynamics, Inc., Vygon Ltd. and others. Major enterprises are developing new stents with advanced mesh technologies with combined biological solutions. Merger and acquisitions, partnerships and improved R&D on bioresorbable vascular scaffolds will drive the market growth in the near future.

Historical & Forecast Period

This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Bioresorbable Vascular Scaffold market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Bioresorbable Vascular Scaffold market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Bioresorbable Vascular Scaffold market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2033.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Bioresorbable Vascular Scaffold market?
• Which is the largest regional market for Bioresorbable Vascular Scaffold market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Bioresorbable Vascular Scaffold market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Bioresorbable Vascular Scaffold market worldwide?